# Highly efficient expression of DNA-peptide conjugates in growth-arrested cells

## TL;DR

This paper introduces a new method for efficiently delivering DNA into the nucleus of growth-arrested cells using DNA-peptide conjugates, significantly improving gene expression.

## Contribution

A modular workflow using E. coli tRNA guanine transglycosylase to create DNA-PepTAG conjugates for enhanced nuclear delivery of DNA.

## Key findings

- NLS-modified gene cassettes increase nuclear localization, mRNA transcription, and expression up to ~10 fold in growth-arrested cells.
- PLSCR-1 and extSV40 NLS peptides show consistently high expression across tested cell types.
- The approach works for DNA payloads encoding cytosolic, secreted proteins, and gene cassettes up to 7 kbp in size.

## Abstract

Efficient nuclear delivery of DNA remains a major challenge in non-viral gene therapy. While nuclear localization signal (NLS) peptides have been explored for enhancing nuclear translocation of DNA, their efficacy has been limited by DNA-peptide conjugation strategies. Leveraging E. coli tRNA guanine transglycosylase, we present a modular workflow for generating DNA oligonucleotide-peptide conjugates which are ligated to linear DNA to generate peptide-modified gene cassettes (DNA-PepTAG). Using an eGFP reporter delivered via lipofection to growth-arrested cells, NLS-modified gene cassettes significantly increases nuclear localization, mRNA transcription, and expression up to ~10 fold compared to unmodified gene cassettes. Screening multiple NLS peptides in growth-arrested human cell lines reveal cell-type-specific preferences for nuclear translocation of DNA cargo. Two NLS peptides, PLSCR-1 and extSV40, exhibit consistently high expression across tested cell types, indicating broad applicability for nuclear delivery. We evaluate the generality of our approach by delivering DNA payloads encoding for both cytosolic and secreted proteins, as well as gene cassettes ranging in size from 1.3 kbp to 7 kbp. These findings support the potential of DNA-NLS conjugates as a viable strategy for non-viral gene therapy, enabling enhanced nuclear delivery of therapeutic genes while minimizing the required DNA dose.

Efficient nuclear delivery of DNA remains a major challenge in non-viral gene therapy. Here the authors present an improved workflow for generating DNA oligonucleotide-peptide conjugates which are ligated to linear DNA and achieve nuclear localization.